USPTO serial 79287309
ONCOPEPTIDES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 15, 2021
- Examiner
- FARRELL, ANNE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ONCOPEPTIDES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John C. McElwaine
John C. McElwaine Nelson Mullins Riley & Scarborough LLP301 South College StreetSuite 2300, IP DepartmentCharlotte, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations and substances for use as pharmaceutical intermediates; chemical products for use in pharmaceuticals | ACTIVE | — |
| 005 | Pharmaceutical, medicinal and veterinary preparations and substances for use in the treatment of cancer, neoplastic diseases, multiple myeloma and amyloidosis; chemical preparations for medical use for use in the treatment of hematological diseases, cancer, neoplastic diseases and multiple myeloma and amyloidosis; drug delivery agents in the form of conjugates that facilitate the delivery of pharmaceutical preparations | ACTIVE | — |
| 042 | Pharmaceutical research services; biomedical research services; chemical research services; development of pharmaceutical preparations and medicines; laboratory research and analysis services in the field of pharmaceuticals; laboratory testing services in the field of pharmaceuticals; medical laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oncopeptides AB
- Other trademarks owned by Oncopeptides AB
- Other trademarks owned by Oncopeptides AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ONCOPEPTIDES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 4, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 30, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 30, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 30, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 15, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 15, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 28, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 10, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 10, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 29, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 23, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |